Oncolys BioPharma (TSE:4588) Accounts Payable: 円0.0 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:4588 Oncolys BioPharma Inc TSE:4588
52 GF Score
Price 円6,160.00
GF Value 円6,632.25
Valuation Fairly Valued
! 8 Warning Signs
View Full Analysis

What is Oncolys BioPharma Accounts Payable?

Oncolys BioPharma TSE:4588 +7.32% 52 Accounts Payable is 円0.0 Mil as of Jun. 2026. GuruFocus rates TSE:4588 with a GF Score™ of 52/100 and a GF Value™ of 円6,632.25 (Fairly Valued). The stock has 8 warning signs investors should review.

Oncolys BioPharma's Accounts Payable for the quarter that ended in Jun. 2026 was 円0.0 Mil.

Oncolys BioPharma Accounts Payable Related Terms

Oncolys BioPharma Accounts Payable Historical Data

* Premium members only.

The historical data trend for Oncolys BioPharma's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Oncolys BioPharma Accounts Payable Chart

Oncolys BioPharma Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Accounts Payable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Oncolys BioPharma Quarterly Data
Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25 Jun26
Accounts Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
TSE:4588
52GF Score
Oncolys BioPharma Inc TSE:4588
Accounts Payable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Oncolys BioPharma Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Frequently Asked Questions Learn more about Accounts Payable →
What does a Accounts Payable of 円0.0 Mil mean?
Oncolys BioPharma (TSE:4588) has a Accounts Payable of 円0.0 Mil as of Jun. 2026. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Oncolys BioPharma and its competitors.
Is Oncolys BioPharma's Accounts Payable too high?
Oncolys BioPharma's current Accounts Payable is 円0.0 Mil. Overall, Oncolys BioPharma has a GF Score™ of 52/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Oncolys BioPharma's Accounts Payable compare to VRTX and REGN?
Oncolys BioPharma's Accounts Payable of 円0.0 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Accounts Payable for a Biotechnology company?
A good Accounts Payable depends on the Biotechnology industry context. However, Accounts Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Accounts Payable mean?
A high Accounts Payable can signal that a stock is expensive relative to its fundamentals. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Oncolys BioPharma and its competitors. Oncolys BioPharma's current Accounts Payable is 円0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Oncolys BioPharma stock overvalued right now?
Based on GuruFocus' analysis, Oncolys BioPharma (TSE:4588) is currently considered Fairly Valued. The stock's GF Value™ is 円6,632.25, compared to a current price of 円6,160.00 — trading 7.1% below its estimated fair value. The current Accounts Payable is 円0.0 Mil. Oncolys BioPharma's overall GF Score™ is 52/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Accounts Payable calculated?
Accounts Payable is calculated from a company's financial statements. For Oncolys BioPharma (TSE:4588), the current Accounts Payable is 円0.0 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Oncolys BioPharma (TSE:4588) Overvalued in 2026?

Based on GuruFocus' analysis, Oncolys BioPharma stock appears to be undervalued. The current stock price of 円6,160.00 is trading 7.1% below its estimated GF Value™ of 円6,632.25. GuruFocus considers Oncolys BioPharma to be Fairly Valued.

Key valuation signals for TSE:4588:

  • Accounts Payable: 円0.0 Mil
  • GF Value™: 円6,632.25 vs. price of 円6,160.00 (7.1% below fair value)
  • GF Score™: 52/100 with 8 warning signs

No single metric tells the full story. See the TSE:4588 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Oncolys BioPharma Business Description

Address 4-1-28 Toranomon, Toranomon Towers Office, Minato-ku, Tokyo, JPN, 105-0001
Oncolys BioPharma Inc develops pharmaceutical products. The company is a biopharmaceutical company focused on developing therapies for cancer treatment. Their product pipeline includes various drug candidates such as Telomelysin (OBP-301) and OBP-702, aimed at addressing unmet medical needs in oncology. The company targets healthcare providers and institutions involved in cancer care and research.
52GF Score

Get the complete analysis for TSE:4588

Accounts Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円6,160.00
Price
円6,632.25
GF Value